Home
About
FAQ
History (19)
D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care.
Botulinum toxin for the treatment of movement disorders.
Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta-analysis consisting 2.8 million adults with 57 294 cases of dementia.
Family with BCL11B Related Dystonia and Movement Disorders.
Psychogenic (Functional) Movement Disorders.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Psychogenic (Functional) Movement Disorders.
Thenganatt MA, Jankovic J. Psychogenic (Functional) Movement Disorders. Continuum (Minneap Minn). 2019 Aug; 25(4):1121-1140.
View in:
PubMed
subject areas
Adolescent
Adult
Female
Humans
Middle Aged
Movement Disorders
Neurologic Examination
Physical Therapy Modalities
Somatoform Disorders
authors with profiles
Mary Ann Thenganatt MD